USPTO serial 79293649
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded and downloadable software for medical purposes, namely, software for use in allowing users to query an analytical system in the field of healthcare and pharmaceutical products; recorded and downloadable software applications for medical purposes, namely, intelligent personal assistant software for voice recognition and natural language processing for the purposes of monitoring and improving patient health; recorded and downloadable computer software, namely, chatbot software enabling users to use natural voice to query an analytical system through a Web page or mobile tool for generating and simulating conversations in the field of health and pharmaceutical products; recorded and downloadable software applications for medical applications, namely, software for collecting, processing, transmitting and displaying medical data collected from medical patient monitoring equipment; downloadable mobile applications for receiving, processing, transmitting data collected from patients and from patient monitoring equipment for the purpose of providing information regarding pharmaceutical products and healthcare; data collection devices, namely, electronic monitors for use in receiving, processing, transmitting and displaying medical data collected from patients and from medical patient monitoring equipment | SECTION 70 - CANCELLED | — |
| 042 | Providing medical and scientific research information in the field of pharmaceutical and clinical trials and studies; providing scientific information in the field of pharmaceutical and clinical trials and studies via the Internet, electronic media and data banks; provision of scientific information in the field of pharmaceutical and clinical trials and studies concerning clinical study results and clinical study data by means of interactive web sites; providing scientific information in the field of pharmaceutical and clinical trials and studies via Internet pages, electronic tools and data banks; provision of scientific information in the field of pharmaceutical and clinical trials and studies concerning clinical studies and results thereof from a data bank which can be consulted online; providing on-line non-downloadable software applications for providing medical and scientific research information in the field of pharmaceutical and clinical trials and studies | SECTION 70 - CANCELLED | — |
| 044 | Providing medical and health information; providing medical information via Internet pages, electronic tools and databases | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 6, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 30, 2020 | ALIE | ASSIGNED TO LIE | — |
| Nov 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 30, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 30, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 6, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 5, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 2, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 2, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 2, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 2, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 2, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |